Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZLI CAT in Cystic Fibrosis
NCT01641822Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2012
- Primary completion
- Jan 2015
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aztreonam in cystic fibrosis (CF), sponsored by Gilead Sciences. Started Dec 2012; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01641822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641822.